Английская Википедия:Efpeglenatide

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Infobox drug

Efpeglenatide is a GLP-1 receptor agonist under development for the treatment of type 2 diabetes and obesity and reducing the risk of cardiovascular incidents in people with these conditions.[1][2][3][4][5][6][7] Its developer is Hanmi Pharmaceutical.[8]

References

Шаблон:Reflist